Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOW study in nonsevere hemophilia A and hemophilia A carriers treated with factor VIII
NL-OMON46704Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Factor VIII in hemophilia A, sponsored by Amsterdam University Medical Center. Primary endpoints: Identification of immune-system markers associated with inhibitor development, Identification of systemic inflammation markers associated with anti-factor VIII immune response risk and 3 more. Started Jun 2018; status: recruiting.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NL-OMON46704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46704.